Literature DB >> 8694528

Lipids in bone tumors assessed by magnetic resonance: chemical shift imaging and proton spectroscopy in vivo.

F Schick1, S H Duda, O Lutz, C D Claussen.   

Abstract

The methods of fat and water selective magnetic resonance (MR) imaging and localized 1H MR spectroscopy were evaluated in the course of 37 examinations on 27 primary bone tumors. These methods are capable of demonstrating small amounts of lipids inside the tumors and subtle edema in the adacent bone marrow, in contrast to the usually applied spin-echo and gradient-echo sequences providing signals dependent on the total proton density and on the relaxation times. The tumor masses of the malignant tumors were free of signals in the fat selective images, whereas in three out of six osteochondroma fat signals could be detected. Localized MR spectroscopy was more sensitive even to very low lipid content (lipid portion < 0.5%) in the tumors and revealed signals with J-coupling from seven out of 13 malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694528

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women.

Authors:  W Shen; J Chen; M Punyanitya; S Shapses; S Heshka; S B Heymsfield
Journal:  Osteoporos Int       Date:  2006-12-01       Impact factor: 4.507

2.  Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: the CARDIA study.

Authors:  Wei Shen; Rebecca Scherzer; Madeleine Gantz; Jun Chen; Mark Punyanitya; Cora E Lewis; Carl Grunfeld
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

3.  Possible effects of EXT2 on mesenchymal differentiation--lessons from the zebrafish.

Authors:  Malgorzata I Wiweger; Carlos E de Andrea; Karel W F Scheepstra; Zhe Zhao; Pancras C W Hogendoorn
Journal:  Orphanet J Rare Dis       Date:  2014-03-14       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.